A 96-Week Comparison of Lopinavir-Ritonavir Combination Therapy Followed by Lopinavir-Ritonavir Monotherapy versus Efavirenz Combination Therapy by Cameron, D. William, da Silva, Barbara A., Arribas, Jose R., Myers, Robert A., Bellos, Nicholaos C., Gilmore, Norbert, King, Martin S., Bernstein, Barry M., Brun, Scott C., Hanna, George J.

Get full text

T-1249 Retains Potent Antiretroviral Activity in Patients Who Had Experienced Virological Failure while on an Enfuvirtide-Containing Treatment Regimen by Lalezari, Jacob P., Bellos, Nicholaos C., Sathasivam, Kunthavi, Richmond, Gary J., Cohen, Calvin J., Myers, Robert A., Henry, David H., Raskino, Claire, Melby, Tom, Murchison, Hugh, Zhang, Ying, Spence, Rebecca, Greenberg, Michael L., DeMasi, Ralph A., Miralles, G. Diego

Get full text

Abacavir Expanded Access Program for Adult Patients Infected with Human Immunodeficiency Virus Type 1 by Kessler, Harold A., Johnson, Judy, Follansbee, Stephen, Sension, Michael G., Mildvan, Donna, Sepulveda, Gladys E., Bellos, Nicholaos C., Hetherington, Seth V.

Get full text

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation by Pereyra, Florencia, Jia, Xiaoming, McLaren, Paul J, Telenti, Amalio, de Bakker, Paul I W, Walker, Bruce D, Ripke, Stephan, Brumme, Chanson J, Pulit, Sara L, Carrington, Mary, Kadie, Carl M, Carlson, Jonathan M, Heckerman, David, Graham, Robert R, Plenge, Robert M, Deeks, Steven G, Gianniny, Lauren, Crawford, Gabriel, Sullivan, Jordan, Gonzalez, Elena, Davies, Leela, Camargo, Amy, Moore, Jamie M, Beattie, Nicole, Gupta, Supriya, Crenshaw, Andrew, Burtt, Noël P, Guiducci, Candace, Gupta, Namrata, Gao, Xiaojiang, Qi, Ying, Yuki, Yuko, Piechocka-Trocha, Alicja, Cutrell, Emily, Rosenberg, Rachel, Moss, Kristin L, Lemay, Paul, O'Leary, Jessica, Schaefer, Todd, Verma, Pranshu, Toth, Ildiko, Block, Brian, Baker, Brett, Rothchild, Alissa, Lian, Jeffrey, Proudfoot, Jacqueline, Alvino, Donna Marie L, Vine, Seanna, Addo, Marylyn M, Allen, Todd M, Altfeld, Marcus, Henn, Matthew R, Le Gall, Sylvie, Streeck, Hendrik, Haas, David W, Kuritzkes, Daniel R, Robbins, Gregory K, Shafer, Robert W, Gulick, Roy M, Shikuma, Cecilia M, Haubrich, Richard, Riddler, Sharon, Sax, Paul E, Daar, Eric S, Ribaudo, Heather J, Agan, Brian, Agarwal, Shanu, Ahern, Richard L, Allen, Brady L, Altidor, Sherly, Altschuler, Eric L, Ambardar, Sujata, Anastos, Kathryn, Anderson, Ben, Anderson, Val, Andrady, Ushan, Antoniskis, Diana, Bangsberg, David, Barbaro, Daniel, Barrie, William, Bartczak, J, Barton, Simon, Basden, Patricia, Basgoz, Nesli, Bazner, Suzane, Bellos, Nicholaos C, Benson, Anne M, Berger, Judith, Bernard, Nicole F, Bernard, Annette M, Birch, Christopher, Bodner, Stanley J, Bolan, Robert K, Boudreaux, Emilie T, Bradley, Meg, Braun, James F, Brndjar, Jon E, Brown, Stephen J, Brown, Katherine, Brown, Sheldon T

Get full text

Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans by MCLAREN, Paul J, RIPKE, Stephan, GUPTA, Namrata, HAAS, David W, DEEKS, Steven G, PEREYRA, Florencia, WALKER, Bruce D, DE BAKKER, Paul I. W, PELAK, Kimberly, WEINTROB, Amy C, PATSOPOULOS, Nikolaos A, XIAOMING JIA, ERLICH, Rachel L, LENNON, Niall J, KADIE, Carl M, HECKERMAN, David

Get full text

Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial by Fischl, Margaret A., Burnside Jr, Alfred F., Farthing, Charles F., Thompson, Melanie A., Bellos, Nicholaos C., Williams, Vanessa C., Kauf, Teresa L., Wannamaker, Paul G., Shaefer, Mark S.

Get full text

The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early tre... by Ruane, PJ, Brinson, C, Ramgopal, M, Ryan, R, Coate, B, Cho, M, Kakuda, TN, Anderson, D

Get full text